https://doi.org/10.4081/itjm.2010.223

Patients at risk for contrast-induced acute kidney injury

Vol. 4 No. 4 (2010)
Submitted: 26 April 2013
Accepted: 26 April 2013
Published: 30 April 2013
Contrast nephropathy, Acute kidney damage, Iodinated contrast media.
Abstract Views: 649
PDF: 1083
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Michele Meschi
paola.granata@pagepress.org
Simona Detrenis
Marcella Saccò
Marcello Bertorelli
Enrico Fiaccadori
Alberto Caiazza
Giorgio Savazzi
Subjects with hypovolemia and/or dehydration and pre-existing renal failure are considered at highest risk for radiocontrast-medium-induced acute kidney injury (RCI-AKI), and this risk increases in the presence of glomerular filtration rate or creatinine clearance rates lower than 60 mL/min (stage 3-5 chronic kidney disease according to the National Kidney Foundation). The authors critically review the evidence-based literature on RCI-AKI, its diagnosis, epidemiological aspects, predisposing conditions, and markers of risk, including advanced age. Procedures requiring the use of iodinated contrast media are increasingly performed in patients over 70 years of age, and there is no definitive consensus regarding the role of advanced age as a marker of risk for RCI-AKI.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Meschi, M., Detrenis, S., Saccò, M., Bertorelli, M., Fiaccadori, E., Caiazza, A., & Savazzi, G. (2013). Patients at risk for contrast-induced acute kidney injury. Italian Journal of Medicine, 4(4), 223–229. https://doi.org/10.4081/itjm.2010.223

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.